Skip to main content
. 2011 Jun;49(6):2121–2131. doi: 10.1128/JCM.02373-10

Table 2.

GyrA and ParC amino acid substitutions and detection of class 1 integrons in select Acinetobacter isolates obtained from correctional facilitiesa

Isolate code Species typing FQ breakpoint
Change in GyrA amino acid:
Change in ParC amino acid:
Aminoglycoside breakpoint
Class 1 integron detection
CIP GAT LVX Gly-81 (GGT) Ser-83 (TCA) Ala-84 (GCT) Glu-87 (GAA) Ser-80 (TCG) Glu-84 (GAA) AMK GEN TOB Presence of integrase Cassette organization
CCF-34A A. baumannii (clone II) R R R Leu (TTA) Leu (TTG) S S S
CCF-40A A. baumannii (clone I) R R R Leu (TTA) Leu (TTG) R R R + aacA4-catB8-aadA1
CCF-43A A. baumannii R R R Leu (TTA) Leu (TTG) S S S +
CCF-45A A. baumannii (clone II) R R R Leu (TTA) Leu (TTG) R R R + aacA4-catB8-aadA1
CCF-46A A. baumannii (clone II) R R R Leu (TTA) Leu (TTG) R R R + aacA4-catB8-aadA1
CCF-55A A. baumannii R R R Leu (TTA) Phe (TTT) I S R + aac(6′)-Im-(aadA1/IS26/aadA1)
CCF-56A A. baumannii (clone I) R R R Leu (TTA) Leu (TTG) R R R
CCF-63A A. baumannii (clone I) R R R Leu (TTA) Leu (TTG) R R R + aacA4-catB8-aadA1
CCF-92A A. baumannii R R R Leu (TTA) Leu (TTG) S S S
CCF-96A gen. sp. 3 R I I S S S
CCF-104A A. baumannii R R R Leu (TTA) Leu (TTG) S S S
CCF-120A gen. sp. 14BJ S S S Leu (TTG) S S S
CCF-08C A. baumannii (clone II) R R R Leu (TTA) Leu (TTG) R R R + aacA4-catB8-aadA1
CCF-09C A. baumannii (clone II) R R R Leu (TTA) Leu (TTG) R R R + aacA4-catB8-aadA1
CCF-54C A. baumannii (clone II) R R R Leu (TTA) Leu (TTG) R R R + aacA4-catB8-aadA1
CCF-61C A. baumannii (clone II) R R R Leu (TTA) Leu (TTG) R R R + aacA4-catB8-aadA1
CCF-94C A. baumannii (clone II) R R R Leu (TTA) Leu (TTG) R R R
CCF-75G A. baumannii R S S Cys S S S
CCF-19H A. baumannii R S S Leu (TTA) S I I
CCF-27H A. baumannii R I S Leu (TTA) S S S
CCF-37I A. baumannii (clone II) R R R Leu (TTA) Leu (TTG) S S S
CCF-102I A. baumannii I S S S S S
CCF-20J gen. sp. 14BJ S S S Leu (TTG) S S S
CCF-59M A. baumannii R R R Leu (TTA) Leu (TTG) R R R
CCF-70M A. baumannii (clone II) R R R Leu (TTA) Leu (TTG) S R S
CCF-82M A. baumannii R R R Leu (TTA) Leu (TTG) S S S
CCF-86M A. baumannii R R R Leu (TTA) Leu (TTG) S R R + aadB-aadA2
CCF-93M A. baumannii (clone II) R R R Leu (TTA) Leu (TTG) S R R + aadB-aadA2
CCF-108M A. baumannii R R R Leu (TTA) Leu (TTG) S S S
CCF-121M A. baumannii R S S S R I
CCF-68Q A. baumannii R R R Leu (TTA) Leu (TTG) S R R + aadB-aadA2
CCF-97Q A. baumannii R I I Leu (TTA) Leu (TTG) S R R + aadB-aadA2
CCF-129Q A. baumannii R R R Leu (TTA) Leu (TTG) S R R + aadB-aadA2
a

Shown here are only isolates intermediate or resistant to relevant antibiotics, mutant genotype in the gyrA or parC QRDR, or positive with class 1 integrase PCR; all other isolates had identical susceptible phenotypes, were wild type in the gyrA or parC QRDR, and were negative in class 1 integrase PCR. −, No change from the wild type. Wild-type amino acids and codons are from published sequences (GenBank accession no. X82165 for gyrA and GenBank accession no. X95819 for parC). Isolates were designated susceptible (S), intermediate (I), or resistant (R) according to antibiotic breakpoint guidelines of the CLSI (10) for Acinetobacter spp. Antibiotic abbreviations: AMK, amikacin; CIP, ciprofloxacin; GAT, gatifloxacin; GEN, gentamicin; LVX, levofloxacin; and TOB, tobramycin.